Literature DB >> 11872970

Obesity, diabetes, and risk of cardiovascular disease in the elderly.

Peter W F Wilson1, William B Kannel.   

Abstract

There is an age-related increase in total body fat and visceral adiposity until age 65 years that often is accompanied by diabetes or impaired glucose tolerance. The prevalence of type 2 diabetes increases progressively with age, peaking at 16.5% in men and 12.8% in women at age 75-84 years. Over age 65, diabetes or glucose intolerance was present in 30%-40% of Framingham Study subjects. There has been an alarming increase, of epidemic proportions, in both obesity and diabetes in the general population. Type 2 diabetes and obesity are both associated with a clustering of atherogenic risk factors, and when three or more are present it generally signifies an insulin resistance syndrome. This is promoted by weight gain and visceral adiposity. The risk of macrovascular disease is increased before glucose levels reach the diagnostic threshold for "diabetes," and 25% of newly diagnosed diabetics already have overt cardiovascular disease. In the Framingham Study, increased risk of cardiovascular disease was two-fold in men and three-fold in women, eliminating the female advantage over men for all outcomes except stroke. Coronary disease is the most common and lethal sequela, and unrecognized myocardial infarctions are three times more common in diabetic than nondiabetic men. Following a myocardial infarction, diabetes imposes a high rate of recurrence, heart failure, and death, more so in women than men. The risk of cardiovascular sequelae in diabetics is variable, the majority of events occurring in those with two or more additional risk factors. Because of the variable risk of cardiovascular disease in either the diabetic or obese person, risk stratification is necessary to determine the hazard of impending cardiovascular disease. This is readily accomplished with Framingham cardiovascular risk formulations. For persons with diabetes or obesity, the chief goal is to avoid the common cardiovascular sequelae. Comprehensive care should include not only normalization of the blood sugar, but also weight reduction, dietary fat restriction, strict blood pressure and lipid control, exercise, and avoidance of tobacco. Trial data indicate that preventive measures benefit obese diabetics even more than nondiabetics. (c)2002 CVRR, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11872970     DOI: 10.1111/j.1076-7460.2002.00998.x

Source DB:  PubMed          Journal:  Am J Geriatr Cardiol        ISSN: 1076-7460


  35 in total

Review 1.  Exercise training: can it improve cardiovascular health in patients with type 2 diabetes?

Authors:  K J Stewart
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

2.  Aging, metabolic syndrome and the heart.

Authors:  Guarner Veronica; Rubio-Ruiz Maria Esther
Journal:  Aging Dis       Date:  2012-03-13       Impact factor: 6.745

3.  A comparative analysis of the occupational energy expenditure of radiologists versus clinicians.

Authors:  I G Murphy; C G Murphy; E J Heffernan
Journal:  Ir J Med Sci       Date:  2014-10-24       Impact factor: 1.568

Review 4.  Obesity cardiomyopathy and systolic function: obesity is not independently associated with dilated cardiomyopathy.

Authors:  Muhammad Fahad Khan; Mohammad Reza Movahed
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

5.  Provision of counseling on diabetes self-management: are there any age disparities?

Authors:  Samuel N Forjuoh; Charles Huber; Jane N Bolin; Shivajirao P Patil; Manisha Gupta; Janet W Helduser; Sonia Holleman; Marcia G Ory
Journal:  Patient Educ Couns       Date:  2010-09-21

6.  Predicting the risk of cardiovascular comorbidities in adult cancer survivors.

Authors:  A Y Tashakkor; A Moghaddamjou; L Chen; W Y Cheung
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

Review 7.  Validation of anti-aging drugs by treating age-related diseases.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-03-28       Impact factor: 5.682

Review 8.  Mitochondria and oxidative stress in heart aging.

Authors:  Beatriz Martín-Fernández; Ricardo Gredilla
Journal:  Age (Dordr)       Date:  2016-07-24

Review 9.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).

Authors:  Dana E King; Arch G Mainous; Brent M Egan; Robert F Woolson; Mark E Geesey
Journal:  Ann Fam Med       Date:  2008 Mar-Apr       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.